Trial results may be difficult to interpret because of different (possibly inconsistent) efficacy results across the pivotal studies. This may be due to differences in the trial populations associated with differences in efficacy across important sub-populations.
Results for an individual trial may vary in magnitude and/or direction for different outcomes, making interpretation less straightforward, for example when reviewing results for individual components of composite endpoints.